Arab Drug and Chemical Industries shareholders approved yesterday in an extraordinary general meeting paid-in capital increase by EGP 19.5 million from EGP 40.5 million to EGP 60 million at EGP 10 par value plus issue costs each.
Shareholders authorized the board to amend articles of incorporation No. 6 and 6 bis.
The ordinary general meeting also ratified the estimated budget for FY14/15 targeting EGP 4.4 million net profit.
The company had posted EGP 1.8 million net profit before tax in H1-13/14.
Shareholders authorized the board to amend articles of incorporation No. 6 and 6 bis.
The ordinary general meeting also ratified the estimated budget for FY14/15 targeting EGP 4.4 million net profit.
The company had posted EGP 1.8 million net profit before tax in H1-13/14.
Source:
Mubasher
